
March 29, 2025
Study Finds Oral Semaglutide Vastly Reduces Heart Attacks, Strokes
A large clinical trial, co-led by researchers at the UNC School of Medicine, has shown that the popular weight-loss drug significantly reduces cardiovascular events in people with type 2 diabetes, pre-existing cardiovascular disease, and/or chronic kidney disease.